5-2 CR for Diabetes

"Yes, this is an ongoing trial that was first posted on June 22nd, 2015. The study requires 150 patients from a single location and has been edited most recently on October 31st, 2022."

"While there is some evidence indicating that the Boost 5-2 diet is safe, as it is only a Phase 2 trial, there is no concrete data supporting its efficacy. Consequently, our team has given it a score of 2."

"The age range this study is recruiting in is between 55 and 70 years old."

"This clinical trial is recruiting 150 participants with diabetes mellitus aged 55 and 70 who meet the following criteria: - history of eating disorders, significant GI disorders or malabsorption disorders;- HOMA-IR greater than or equal to 1.8; - MMSE greater than or equal to 26; - no clinically significant endocrine disorders (common mild endocrine disorders, such as untreated subclinical hypothyroidism with TSH < 10 mU/l or successfully treated hypothyroidism may be allowed); - no clinically significant stroke or other neurological disease of the central nervous"

"That is correct. The clinicaltrials.gov website has information showing that this study is still looking for subjects. This trial was originally posted on June 22nd, 2015 and the most recent update was on October 31st, 2022. Currently, they are recruiting for 150 individuals at 1 site."